Clinical trial
Prospective, Multi Center, Single Group Target Value Study to Evaluate the Safety and Effectiveness of Endovascular Interventional Device Control System and Supporting Consumables for Coronary Intervention
NCT05642286 is registered in ClinicalTrials.gov with Shanghai Operation Robot Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi Center, Single Group Target Value Study to Evaluate the Safety and Effectiveness of Endovascular Interventional Device Control System and Supporting Consumables for Coronary Intervention
- Lead sponsor
- Shanghai Operation Robot Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 218 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, percutaneous coronary intervention, robotic surgical procedures